CARS2 and pulmonary fibrosis: Cars2+/− mice treated with bleomycin, compared with WT mice treated with bleomycin, showed increased body weight loss and worsened lung fibrosis as evaluated by 3D morphometric analysis with micro-CT (Fig. 10a–c).